Combined Genotype Analyses of Precursor miRNA-196a2 and -499a Variants with Hepatic and Renal Cancer Susceptibility- a Preliminary Study |
Toraih, Eman A
(Department of Histology and Cell Biology (Genetics Unit))
Fawzy, Manal S (Department of Medical Biochemistry, Faculty of Medicine, Suez Canal University) Elgazzaz, Mona G (Department of Histology and Cell Biology (Genetics Unit)) Hussein, Mohammad H (Ministry of Health) Shehata, Rasha H (Department of Tropical Medicine and Gasteroenterology, Assuit University) Daoud, Hisham G (Department of Electrical Engineering, Faculty of Engineering, Canadian International College) |
1 | De la Chapelle A, Jazdzewski K (2011). MicroRNAs in thyroid cancer. J Clin Endocrinol Metab, 96, 3326-36. DOI |
2 | Du M, Lu D, Wang Q, et al (2014). Genetic variations in microRNAs and the risk and survival of renal cell cancer. Carcinogenesis, 35, 1629-35. DOI |
3 | Geeleher P, Huang SR, Gamazon ER, Golden A, Seoighe C (2012). The regulatory effect of miRNAs is a heritable genetic trait in humans. BMC Genomics, 3, 383. |
4 | Guo J, Jin M, Zhang M, Chen K (2012). A genetic variant in miR-196a2 increased digestive system cancer risks: a metaanalysis of 15 case-control studies. PLoS ONE, 7, 30585. DOI |
5 | He B, Pan Y, Cho WC, et al (2012). The Association between Four Genetic Variants in MicroRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PLoS ONE, 7, 49032. DOI |
6 | Hoffman AE, Zheng T, Yi C, et al (2009). microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res, 69, 5970-7. DOI |
7 | Hornstein E, Mansfield JH, Yekta S, et al (2005). The microRNA miR-196 acts upstream of Hoxb8 sand Shh in limb development. Nature, 438, 671-4. DOI |
8 | Hou W, Tian Q, Zheng J, Bonkovsky HL (2010). MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins. Hepatol, 51, 1494-504. DOI |
9 | Hu Z, Liang J, Wang Z, et al (2009). Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat, 30, 79-84. DOI |
10 | Hu Z, Chen J, Tian T, et al (2008). Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest, 118, 2600-8. |
11 | Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M (2004). The KEGG resource for deciphering the genome. Nucleic Acids Res, 32, 277-80. DOI |
12 | Kar P (2014). Risk factors for hepatocellular carcinoma in India. J Clin Exp Hepatol, 4, S34-S42. |
13 | Kim WH, Min KT, Jeon YJ, et al (2012). Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene, 504, 92-7. DOI |
14 | Kwak MS, Lee DH, Cho Y, et al (2012). Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients. PLoS ONE, 27, 41983. |
15 | Li XD, Li ZG, Song XX, Liu CF (2010). A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathol, 42, 669-73. DOI |
16 | Liu Y, Zhang Y, Wen J, et al (2012). A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma. PLoS ONE, 7, 32230. DOI |
17 | Min KT, Kim JW, Jeon YJ, et al (2012). Association of the miR-146aC>G, 149C>T, 196a2C>T, and 499A>G polymorphisms with colorectal cancer in the Korean population. Mol Carcinog, 51, 65-73. DOI |
18 | Moradpour D, Blum HE (2005). Pathogenesis of hepatocellular carcinoma. Eur J Gastroenterol Hepatol, 17, 477-83. DOI |
19 | Morishita A, Masaki T (2015). miRNA in hepatocellular carcinoma. Hepatol Res, 45, 128-41. DOI |
20 | Muglia VF, Prando A (2015). Renal cell carcinoma: histological classification and correlation with imaging findings. Radiol Bras, 48, 166-74. DOI |
21 | Popat K, McQueen K, Feeley TW (2013). The global burden of cancer. Best Pract Res Clin Anaesthesiol, 27, 399-408. DOI |
22 | Qi P, Dou TH, Geng L, et al (2010). Association of a variant in miR-196a2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum Immunol, 71, 1-626. DOI |
23 | Visone R, Croce CM (2009). MiRNAs and cancer. Am J Pathol, 174, 1131-8. DOI |
24 | Qin YR, Tang H, Xie F, et al (2011). Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma. Clin Cancer Res, 17, 46-55. DOI |
25 | Ryan BM, Robles AI, Harris CC (2010). Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer, 10, 389-402. DOI |
26 | Tano K, Mizuno R, Okada T, et al (2010). MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett, 584, 4575-80. DOI |
27 | Vlachos IS, Kostoulas N, Vergoulis T et al (2012). DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res, 40, 498-504. DOI |
28 | Valinezhad Orang A, Safaralizadeh R, Kazemzadeh-Bavili M (2014). Mechanisms of mirna-mediated gene regulation from common downregulation to mRNA-specific upregulation. Int J Genomics, 2014, 970607. |
29 | Xiang Y, Fan S, Cao J, Huang S, Zhang LP (2012). Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Rep, 39, 7019-23. DOI |
30 | Xu W, Xu J, Liu S (2011). Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146aon cancer susceptibility: a meta-analysis. PLoS ONE, 6, 20471. DOI |
31 | Xu Y, Liu L, Liu J, et al (2011). A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular, carcinoma. Int J Cancer, 128, 412-7. DOI |
32 | Chen C, Yang S, Chaugai S, Wang Y, Wan DW (2014). Metaanalysis of Hsa-mir-499 polymorphism (rs3746444) for cancer risk: evidence from 31 case-control studies. BMC Med Genet, 15, 126. |
33 | Akkiz H, Bayram S, Bekar A, Akgollu E, Ulger, Y (2011a). A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. J Viral Hepat, 18, 399-407. DOI |
34 | Akkiz H, Bayram S, Bekar A, Akgollu E, Uskudar O (2011b). Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study. Asian Pac J Cancer Prev, 12, 3107-12. |
35 | Bae JS, Kim JH, Pasaje CF, et al (2012). Association study of genetic variations in microRNAs with the risk of hepatitis B-related liver diseases. Dig Liver Dis, 44, 849-54. DOI |
36 | Bhattacharya A, Cui Y (2015). miR2GO: comparative functional analysis for microRNAs. Bioinformatics, 31, 2403-5. DOI |
37 | Cairns P (2010). Renal cell carcinoma. Cancer Biomark, 9, 461-73. |
38 | Chow WH, Dong LM, Devesa SS (2010). Epidemiology and risk factors for kidney cancer. Nat Rev Urol, 7, 245-57. DOI |
39 | Ye Y, Wang KK, Gu J, et al (2008). Genetic variations in microrna-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res, 1, 460-9. DOI |